1. 180P Recalling pre-existing microbiota-specific T cells to target tumors. (December 2022) Authors: Carpier, J-M.; Talpin, A.; Kulakowski, G.; Dos Santos Leite, A.M.; Laviolette, K.; Noguerol, J.; Mersceman, T.; Garnier, A.; Gaal, C.; Pereira Oliveira, C.; Calderon, C.; Boullerot, L.; Malfroy, M.; Strozzi, F.; Gouttefangeas, C.; Adotevi, O.; Joffre, O.; Gamelas Magalhaes, J.; Chêne, L.; Bonny, C. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 203P Early remodeling of systemic antitumor T cell immunity in head and neck cancer patients treated by chemoradiation. (December 2022) Authors: Lecoester, B.; Seffar, E.; Marguier, A.; Renaudin, A.; Richard, T.; Wespiser, M.; Malfroy, M.; Boullerot, L.; Arnier, R.; Martin, E.; Sun, X.; Laheurte, C.; Boustani, J.; Adotevi, O. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 210P Anti-CTLA-4 overcomes inhibitory effect of PD1high regulatory T cell on circulating antitumor CD4+ Th1 response in patients treated by anti-PD(L)-1. (December 2022) Authors: Marguier, A.; Perreira, V.; Wespiser, M.; Lecoester, B.; Boullerot, L.; Malfroy, M.; Nardin, C.; Laheurte, C.; Orillard, E.; Adotevi, O. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. (4th May 2018) Authors: Adotevi, O.; Godet, Y.; Galaine, J.; Lakkis, Z.; Idirene, I.; Certoux, J. M.; Jary, M.; Loyon, R.; Laheurte, C.; Kim, S.; Dormoy, A.; Pouthier, F.; Barisien, C.; Fein, F.; Tiberghien, P.; Pivot, X.; Valmary-Degano, S.; Ferrand, C.; Morel, P.; Delabrousse, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA6 UCPVax therapeutic vaccination promotes cytotoxic and Th1 polarized antitumor CD4 T cells and epitope spreading in patients with advanced non-small cell lung cancer. (December 2022) Authors: Adotevi, O.; Laheurte, C.; Boullerot, L.; Malfroy, M.; Richard, T.; Cuche, L.; Seffar, E.; Kaulek, V.; Jacquin, M.; Orillard, E.; Eberst, G.; Jandus, C.; Westeel, V.; Borg, C.; Godet, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. (4th May 2018) Authors: Asgarova, A.; Asgarov, K.; Godet, Y.; Peixoto, P.; Nadaradjane, A.; Boyer-Guittaut, M.; Galaine, J.; Guenat, D.; Mougey, V.; Perrard, J.; Pallandre, J. R.; Bouard, A.; Balland, J.; Tirole, C.; Adotevi, O.; Hendrick, E.; Herfs, M.; Cartron, P. F.; Borg, C.; Hervouet, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗